Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 September 2003

Rapid diagnosis of tuberculous meningitis using the Simple Dot ELISA method

Rajpal S. Kashyap, Rani P. Kainthla, Saibal K. Biswas, Neha Agarwal, Nitin Chandak, Hemant J. Purohit, Girdhar M. Taori, Hatim F. Daginawala

Med Sci Monit 2003; 9(11): MT123-126 :: ID: 13393

Abstract

Background:Tuberculous meningitis (TBM) is a serious central nervous system infection, which is seen in clinical practice fairly frequently in developing and underdeveloped countries. Our study was intended to develop a reliable and rapid diagnostic methodology for detecting mycobacterium tuberculous bacilli (MTB) in cerebrospinal fluid (CSF). Dot Enzyme Linked Immunosorbent assay (Dot ELISA) has been standardized to detect MTB antigens and antibodies against MTB in the CSF of TBM patients.Material/Methods:CSF samples were collected from 156 registered patients suffering from various neurological disorders, including 56 cases of TBM. Polyclonal antibodies to Culture Filtrate Protein (CFP), H37Rv strain, an MTB antigen, obtained from Colorado State University (USA), were used to detect MTB antigen in the CSF of TBM patients using the Dot ELISA method.Results:The methodology yielded a positive reaction to MTB antigens in 48 CSF samples (86%) obtained from all 56 cases of suspected TBM. The sensitivity achieved through the developed methodology could give reactivity with an antigen level 10ng/dl and above. Dot ELISA for MTB antigen was positive in only 5 out of 100 (5%) of the other neurological disorders, mainly pyogenic meningitis.Conclusions:This rapid methodology for the detection of MTB antigen in CSF is very simple, sensitive, specific, and cost effective. This technique can be easily and routinely employed in the pathology laboratory to support the clinical diagnosis.

Keywords: Antigens, Antigens, Bacterial, Cerebrospinal Fluid - microbiology, Enzyme-Linked Immunosorbent Assay - methods, Mycobacterium tuberculosis - metabolism, Tuberculosis, Meningeal - diagnosis

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750